There are striking differences in epidemiology (age, race), genetics (HLA II vs HLA I), histopathology (immune-cells comprising the infiltrate), clinical presentation (cranial symptoms and PMR in GCA), imaging (type of lesions and subdiaphragmatic involvement in TAK) and treatment (different responses in TNF-α inhibition). The gene discussed is TNF; the disease is temporal arteritis.